For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
Downloadable powerpoint slideset with key takeways on the use of immune checkpoint inhibitors for resectable early-stage NSCLC, from Clinical Care Options (CCO)
Free video from Clinical Care Options (CCO) featuring expert discussion of the latest updates in immunotherapy for early-stage NSCLC
Drs Enriqueta Felip and Alexander Spira discuss the emerging role of EGFR exon 20 insertion mutations in the management of advanced NSCLC, from Clinical Care Options (CCO)
From Clinical Care Options (CCO), experts review key data in genitourinary, gastrointestinal, breast, and lung cancers presented at the ESMO 2021 congress